Clinical Trials and Research
A Phase II Study of Erlotinib and modified FOLFOX-6
(5-Fluorouracil, Leucovorin and Oxaliplatin) in Previously Untreated Patients with Unresectable or Metastatic Adenocarcinoma of Esophagus and Gastric Cardia.
-
IRB# 07-12-010
-
For more information contact:
- Zev Wainberg, MD
- or Vivian Nguyen
- 310-794-5463
|